VOR: Vor Biopharma Inc. Stock

by  •  • Comments Off on VOR: Vor Biopharma Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 21.32
Enterprise Value ($M) -60.62
Book Value ($M) 96.66
Book Value / Share 0.77
Price / Book 0.22
NCAV ($M) 50.28
NCAV / Share 0.40
Price / NCAV 0.42

Profitability (mra)
Return on Invested Capital (ROIC) -0.91
Return on Assets (ROA) -0.70
Return on Equity (ROE) -0.95

Liquidity (mrq)
Quick Ratio 5.19
Current Ratio 5.19

Balance Sheet (mrq) ($M)
Current Assets 96.51
Assets 142.89
Liabilities 46.23
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -121.19
Net Income -116.91

Cash Flow Statement (mra) ($M)
Cash From Operations -99.66
Cash from Investing 96.86
Cash from Financing 53.39

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13G/A Fmr Llc 5.10 0.04
01-07 13D Reprogrammed Interchange LLC 31.30
12-30 13D/A Ra Capital Management, L.p. 31.90 74.32
11-14 13G/A Paradigm Biocapital Advisors LP 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. 1 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-14 1,653,781 4,206,571 39.31
2025-05-13 1,287,884 4,431,232 29.06
2025-05-12 1,514,723 4,120,306 36.76
2025-05-09 2,061,199 5,542,531 37.19

(click for more detail)

Similar Companies
VERV – Verve Therapeutics, Inc. VIGL – Vigil Neuroscience, Inc.
VIR – Vir Biotechnology, Inc. VRTX – Vertex Pharmaceuticals Incorporated
VTRS – Viatris Inc.


Financial data and stock pages provided by
Fintel.io